Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
With a market cap of 599.17B, Johnson & Johnson(JNJ) trades at $248.63. The stock has a price-to-earnings ratio of 30.57 and currently yields dividends of 2.00%.
As of 2026-10-13, Johnson & Johnson(JNJ) stock has fluctuated between $248.58 and $259.46. The current price stands at $248.63, placing the stock +0.0% above today's low and -4.2% off the high.
The Johnson & Johnson(JNJ)'s current trading volume is 3.94M, compared to an average daily volume of 7.01M.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $184.66.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $281.07 and a 52-week low of $184.66.
JNJ News
Shares of Johnson & Johnson dropped more than 5% Tuesday morning after the company reported weaker-than-expected results from its medical devices division. “We...
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating...
Johnson & Johnson (JNJ Quick QuoteJNJ - Free Report) reported $25.4 billion in revenue for the quarter ended September 2026, representing a year-over-year...
Analyst ratings
70%
of 27 ratingsMore JNJ News
...
Johnson & Johnson (JNJ) reported better-than-expected third-quarter 2026 results on Tuesday, driven by strong pharmaceutical sales. However, JNJ stock fell in p...
Johnson & Johnson (JNJ Quick QuoteJNJ - Free Report) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.53 pe...
Genmab (GMAB) announced that worldwide net trade sales of Darzalex – daratumumab -, including sales of the subcutaneous product sold under the tradename Darzale...
Johnson & Johnson is “leaning” toward spinning out the hips-and-knees business. Jeff Schear / Getty Images Johnson & Johnson JNJ 0.88 %increase; up pointing tr...
Reports Q3 revenue $25.4B, consensus $25.38B. “Johnson & Johnson’s strong third-quarter performance and increased sequential growth reflect the accelerating mom...
has delivered a powerful run for shareholders over the past few years, which puts a sharper spotlight on whether today's valuation is properly backed by its cas...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.